A Real-World Evaluation of Clinical Outcomes of Biologicals and Bronchial Thermoplasty for Severe Refractory Asthma (BIOTERM)

Overview of attention for article published in Journal of Asthma and Allergy, August 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

So far, Altmetric has seen 2 news stories from 2 outlets.

New Published: Sept. 7, 2021 By BioSpace Editorial Staff Tezepelumab is showing potential as a new biological therapy for…

Al Seib / Los Angeles Times via Tezepelumab is showing potential as a new biological therapy for severe refractory asthma.